Adolescents with overweight or obesity and asthma taking a GLP-1 agent had less risk of asthma exacerbations compared with ...

What starts as breathlessness can turn fatal within minutes, doctors warn that quick action, correct inhaler use and timely ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues ...

Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

The study is part of a growing body of research examining the benefits of climate change solutions on human health.

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

On average, 10.6% of Louisiana adults reported ever being told by a health professional that they have asthma. These parishes ...